Revenue Summary of Sirona Biochem Corp.

Sirona Biochem Corp.'s latest annual revenue in 2023 was 34.77 Thousand CAD , down -94.82% from previous year.
Sirona Biochem Corp.'s latest quarterly revenue in 2024 Q3 was 2543.00 CAD , down -77.03% from previous quarter.
Sirona Biochem Corp. reported a annual revenue of 671.92 Thousand CAD in annual revenue 2022, up 150.7% from previous year.
Sirona Biochem Corp. reported a annual revenue of 268.02 Thousand CAD in annual revenue 2021, up 153.54% from previous year.
Sirona Biochem Corp. reported a quarterly revenue of 1571.00 CAD for 2024 Q1, up 104.98% from previous quarter.
Sirona Biochem Corp. reported a quarterly revenue of 2543.00 CAD for 2024 Q3, down -77.03% from previous quarter.

Annual Revenue Chart of Sirona Biochem Corp. (2023 - 2006)

Historical Annual Revenue of Sirona Biochem Corp. (2023 - 2006)

Year	Revenue	Revenue Growth
2023	34.77 Thousand CAD	-94.82%
2022	671.92 Thousand CAD	150.7%
2021	268.02 Thousand CAD	153.54%
2020	105.71 Thousand CAD	-22.12%
2019	135.74 Thousand CAD	-89.38%
2018	1.27 Million CAD	23285.06%
2017	5468.00 CAD	-98.48%
2016	360.5 Thousand CAD	4409.07%
2015	7995.00 CAD	-96.15%
2014	207.73 Thousand CAD	0.0%
2013	- CAD	0.0%
2012	- CAD	0.0%
2011	- CAD	0.0%
2010	- CAD	0.0%
2009	- CAD	0.0%
2008	- CAD	0.0%
2007	- CAD	0.0%
2006	- CAD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	11.07 Thousand CAD	604.84%
2024 Q1	1571.00 CAD	104.98%
2024 Q3	2543.00 CAD	-77.03%
2023 Q2	59.51 Thousand CAD	0.0%
2023 FY	34.77 Thousand CAD	-94.82%
2023 Q1	- CAD	-100.0%
2023 Q4	-31.55 Thousand CAD	-562.95%
2023 Q3	6815.00 CAD	-88.55%
2022 Q4	18.05 Thousand CAD	-97.24%
2022 Q3	653.86 Thousand CAD	242.48%
2022 FY	671.92 Thousand CAD	150.7%
2022 Q1	- CAD	-100.0%
2022 Q2	190.92 Thousand CAD	0.0%
2021 Q1	18.15 Thousand CAD	-82.82%
2021 FY	268.02 Thousand CAD	153.54%
2021 Q2	190.92 Thousand CAD	951.4%
2021 Q4	29.9 Thousand CAD	-86.41%
2021 Q3	219.96 Thousand CAD	15.21%
2020 Q3	- CAD	-100.0%
2020 Q4	105.71 Thousand CAD	0.0%
2020 Q2	527.00 CAD	0.0%
2020 Q1	- CAD	-100.0%
2020 FY	105.71 Thousand CAD	-22.12%
2019 Q2	19.33 Thousand CAD	-70.02%
2019 Q3	- CAD	-100.0%
2019 FY	135.74 Thousand CAD	-89.38%
2019 Q4	71.24 Thousand CAD	0.0%
2019 Q1	64.5 Thousand CAD	-49.12%
2018 FY	1.27 Million CAD	23285.06%
2018 Q4	126.77 Thousand CAD	-78.38%
2018 Q1	562.17 Thousand CAD	27296.59%
2018 Q2	3378.00 CAD	-99.4%
2018 Q3	586.36 Thousand CAD	17258.23%
2017 FY	5468.00 CAD	-98.48%
2017 Q3	2274.00 CAD	355.71%
2017 Q2	499.00 CAD	-22.4%
2017 Q1	643.00 CAD	101.67%
2017 Q4	2052.00 CAD	-9.76%
2016 Q2	393.6 Thousand CAD	15120.46%
2016 Q4	-38.48 Thousand CAD	-1474.08%
2016 Q3	2801.00 CAD	-99.29%
2016 FY	360.5 Thousand CAD	4409.07%
2016 Q1	2586.00 CAD	-67.65%
2015 FY	7995.00 CAD	-96.15%
2015 Q1	- CAD	100.0%
2015 Q4	7995.00 CAD	0.0%
2015 Q3	- CAD	0.0%
2015 Q2	- CAD	0.0%
2014 FY	207.73 Thousand CAD	0.0%
2014 Q4	-52.91 Thousand CAD	0.0%
2014 Q3	- CAD	-100.0%
2014 Q2	205.07 Thousand CAD	269.01%
2014 Q1	55.57 Thousand CAD	0.0%
2013 Q4	- CAD	0.0%
2013 FY	- CAD	0.0%
2013 Q2	- CAD	0.0%
2013 Q1	- CAD	0.0%
2013 Q3	- CAD	0.0%
2012 Q3	- CAD	0.0%
2012 Q2	- CAD	0.0%
2012 FY	- CAD	0.0%
2012 Q1	- CAD	0.0%
2012 Q4	- CAD	0.0%
2011 Q2	- CAD	0.0%
2011 Q3	- CAD	0.0%
2011 Q1	- CAD	0.0%
2011 FY	- CAD	0.0%
2011 Q4	- CAD	0.0%
2010 Q1	- CAD	0.0%
2010 Q4	- CAD	0.0%
2010 Q2	- CAD	0.0%
2010 Q3	- CAD	0.0%
2010 FY	- CAD	0.0%
2009 Q2	- CAD	0.0%
2009 Q3	- CAD	0.0%
2009 FY	- CAD	0.0%
2009 Q4	- CAD	0.0%
2009 Q1	- CAD	0.0%
2008 Q4	- CAD	0.0%
2008 Q3	- CAD	0.0%
2008 FY	- CAD	0.0%
2008 Q1	- CAD	0.0%
2008 Q2	- CAD	0.0%
2007 FY	- CAD	0.0%
2007 Q3	- CAD	0.0%
2007 Q1	- CAD	0.0%
2007 Q4	- CAD	0.0%
2007 Q2	- CAD	0.0%
2006 FY	- CAD	0.0%

Peer Revenue Comparison of Sirona Biochem Corp.

Name	Revenue	Revenue Difference
Eiger BioPharmaceuticals, Inc.	15.77 Million USD	99.78%
Nanobac Pharmaceuticals, Incorporated	17.62 Thousand USD	-97.372%
SQZ Biotechnologies Company	21.47 Million USD	99.838%
Evofem Biosciences, Inc.	18.21 Million USD	99.809%
Santhera Pharmaceuticals Holding AG	122.95 Million USD	99.972%
Mesoblast Limited	5.9 Million USD	99.411%
Propanc Biopharma, Inc.	- USD	-Infinity%
Genus plc	668.8 Million USD	99.995%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
CNBX Pharmaceuticals Inc.	410.16 Thousand USD	91.521%
Marizyme, Inc.	645.81 Thousand USD	94.615%
ContraFect Corporation	- USD	-Infinity%
Nymox Pharmaceutical Corporation	- USD	-Infinity%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	76.76 Thousand USD	54.692%
Intellipharmaceutics International Inc.	65.72 Thousand USD	47.086%
AXIM Biotechnologies, Inc.	39.51 Thousand USD	11.992%
MultiCell Technologies, Inc.	49.32 USD	-70417.032%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	49.72 Million USD	99.93%
EV Biologics, Inc.	48.9 Thousand USD	28.877%
Q BioMed Inc.	284.35 Thousand USD	87.769%
Emmaus Life Sciences, Inc.	29.59 Million USD	99.882%
Neon Bloom, Inc.	- USD	-Infinity%
Mosaic ImmunoEngineering Inc.	- USD	-Infinity%
Biomind Labs Inc.	- USD	-Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Pharming Group N.V.	245.31 Million USD	99.986%
Oncotelic Therapeutics, Inc.	70 Thousand USD	50.316%
Skye Bioscience, Inc.	- USD	-Infinity%
Therapeutic Solutions International, Inc.	98.99 Thousand USD	64.868%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	75.72 Thousand USD	54.071%
IMV Inc.	- USD	-Infinity%
Acro Biomedical Co., Ltd.	658.5 Thousand USD	94.718%
Curative Biotechnology, Inc.	- USD	-Infinity%
GB Sciences, Inc.	- USD	-Infinity%
Alpha Cognition Inc.	- USD	-Infinity%
HST Global, Inc.	- USD	-Infinity%
CSL Limited	14.69 Billion USD	100.0%
Halberd Corporation	999.00 USD	-3381.381%
Enzolytics Inc.	52.79 Thousand USD	34.126%
Resverlogix Corp.	- USD	-Infinity%
Affymax, Inc.	1.36 Million USD	97.46%
SYBLEU INC	11.69 Thousand USD	-197.358%
Nuo Therapeutics, Inc.	608.52 Thousand USD	94.285%
argenx SE	1.22 Billion USD	99.997%
MetaStat, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	1.93 Million USD	98.2%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Arno Therapeutics, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	617.38 Thousand USD	94.367%
Zenith Capital Corp.	- USD	-Infinity%
Genscript Biotech Corporation	839.52 Million USD	99.996%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	- USD	-Infinity%
WPD Pharmaceuticals Inc.	- USD	-Infinity%
American Oriental Bioengineering, Inc.	145.09 Million USD	99.976%
Provectus Biopharmaceuticals, Inc.	557.71 Thousand USD	93.764%
Adynxx, Inc.	- USD	-Infinity%
Helix BioMedix, Inc.	997.72 Thousand USD	96.514%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	48.35 Million USD	99.928%
Cotinga Pharmaceuticals Inc.	- USD	-Infinity%
BioStem Technologies, Inc.	16.68 Million USD	99.792%
ONE Bio Corp.	52.29 Million USD	99.933%
Reve Technologies, Inc.	- USD	-Infinity%
Burzynski Research Institute, Inc.	- USD	-Infinity%
Wesana Health Holdings Inc.	- USD	-Infinity%
Agentix Corp.	- USD	-Infinity%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
ProtoKinetix, Incorporated	- USD	-Infinity%
Regen BioPharma, Inc.	236.56 Thousand USD	85.298%
Regen BioPharma, Inc.	236.56 Thousand USD	85.298%
NovAccess Global Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	140.24 Thousand USD	75.201%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	- USD	-Infinity%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
Kadimastem Ltd	- USD	-Infinity%
Oncology Pharma Inc.	- USD	-Infinity%
Institute of Biomedical Research Corp.	- USD	-Infinity%
CytoDyn Inc.	- USD	-Infinity%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	- USD	-Infinity%
Qrons Inc.	- USD	-Infinity%
Alseres Pharmaceuticals, Inc.	473.73 Thousand USD	92.658%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	- USD	-Infinity%
International Stem Cell Corporation	7.78 Million USD	99.553%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	- USD	-Infinity%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	13 Thousand USD	-167.531%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	- USD	-Infinity%
Neutra Corp.	39.53 Thousand USD	12.028%
Windtree Therapeutics, Inc.	- USD	-Infinity%
PureTech Health plc	3.33 Million USD	98.956%
Coeptis Therapeutics, Inc.	- USD	-Infinity%
IXICO plc	6.66 Million USD	99.478%
IntelGenx Technologies Corp.	1.03 Million USD	96.653%
Gelesis Holdings, Inc.	25.76 Million USD	99.865%
CSL Limited	14.8 Billion USD	100.0%
Cellectis S.A.	755 Thousand USD	95.394%

Global Stocks Search

Sirona Biochem Corp. (SRBCF)

Revenue Summary of Sirona Biochem Corp.

Annual Revenue Chart of Sirona Biochem Corp. (2023 - 2006)

Historical Annual Revenue of Sirona Biochem Corp. (2023 - 2006)

Peer Revenue Comparison of Sirona Biochem Corp.